Withdrawal Of Atrioventricular Nodal Blocking Agents in Patients Receiving Mavacamten: A Retrospective Single-Center Experience in A Predominantly Asian-American Cohort
The American journal of cardiology（2023）
摘要
•Atrioventricular nodal blockers can be safely discontinued after starting mavacamten.•Mavacamten is effective in Asian-American cohorts.•Symptom reduction often occurs at the first visit after initiation.
更多查看译文
关键词
hypertrophic cardiomyopathy,myosin,mavacamten,AVN blocking agents
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要